Target intelligence / Profile preview

Meteorin (METRN)

Target
METRN
Molecular classification
Secreted protein
01

Overview

Meteorin (METRN) is a secreted protein primarily expressed in undifferentiated neural progenitors and the astrocyte lineage, including radial glia, within the central and peripheral nervous systems. It plays a key role in glial cell differentiation by promoting astrocyte formation from cerebrocortical neurospheres and transforming cerebellar astrocytes into radial glia-like cells with elongated processes. Meteorin also supports axonal extension in small and intermediate sensory neurons by acting on nearby satellite glia, inducing their morphological changes and ERK1/2 phosphorylation, which secondarily stimulates neurite outgrowth. The protein consists of approximately 290-293 amino acids in humans and mice, with a signal peptide for secretion but no conserved motifs or transmembrane domains, and shows no significant homology to known proteins beyond its paralog Meteorin-like (Metrnl). Structurally, it features a CUB domain and an NTR domain connected by a hinge region, with predicted receptor-binding sites identified via computational modeling. While associated with rare neural disorders like Charcot-Marie-Tooth disease type 4, Meteorin is not established as a therapeutic receptor or drug target, lacking known interacting drugs or clinical modulators. Its functions highlight potential in neural repair, but limited disease linkages and no membrane receptor identity restrict drug development opportunities.

Other names
Meteoringlial cell differentiation regulator
02

Biological functions

Glial cell differentiationaxonal network formationneurogenesisastrocyte differentiation
03

Disease associations

Charcot-Marie-Tooth disease type 4

Beyond the preview

Go deeper on Meteorin (METRN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meteorin (METRN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call